Cap on Trade Margin of 42 selected non-scheduled anti-cancer medicines

MARCH 28, 2023 As informed by Department of Pharmaceuticals, National Pharmaceutical Pricing Authority vide order S.O. 1041(E) dated 27th February, 2019, has put a cap on Trade Margin of 42 selected non-scheduled anti-cancer medicines on pilot basis under ‘Trade Margin Rationalization’ approach. Ribociclib was also included in this. […]